{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:28:11Z","timestamp":1785554891765,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CDT-142654"],"award-info":[{"award-number":["CDT-142654"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bvth.2025.100111","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T23:13:25Z","timestamp":1759878805000},"page":"100111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["DOACs vs warfarin in AF with comorbid CKD or valvular disease: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0366-1547","authenticated-orcid":false,"given":"Aileen","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5651-1024","authenticated-orcid":false,"given":"Alla E.","family":"Iansavitchene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6869-8431","authenticated-orcid":false,"given":"Alejandro","family":"Lazo-Langner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.bvth.2025.100111_bib1","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.bvth.2025.100111_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.bvth.2025.100111_bib3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.bvth.2025.100111_bib4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"36","key":"10.1016\/j.bvth.2025.100111_bib5","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.bvth.2025.100111_bib6","first-page":"e1","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2023","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bvth.2025.100111_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.bvth.2025.100111_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.bvth.2025.100111_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.bvth.2025.100111_bib11","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.bvth.2025.100111_bib12","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.bvth.2025.100111_bib13","author":"Wells"},{"issue":"3","key":"10.1016\/j.bvth.2025.100111_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000514753","article-title":"Cardiovascular and bleeding outcomes with anticoagulants across kidney disease stages: analysis of a National US cohort","volume":"52","author":"Sy","year":"2021","journal-title":"Am J Nephrol"},{"issue":"17","key":"10.1016\/j.bvth.2025.100111_bib15","first-page":"287","article-title":"Oral anticoagulation in chronic kidney disease and atrial fibrillation","volume":"115","author":"Heine","year":"2018","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"10.1016\/j.bvth.2025.100111_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.23876\/j.krcp.2018.37.2.103","article-title":"Atrial fibrillation and chronic kidney disease: a bad combination","volume":"37","author":"Kiuchi","year":"2018","journal-title":"Kidney Res Clin Pract"},{"issue":"10","key":"10.1016\/j.bvth.2025.100111_bib17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.acvd.2015.06.002","article-title":"How to define valvular atrial fibrillation?","volume":"108","author":"Fauchier","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"issue":"9689","key":"10.1016\/j.bvth.2025.100111_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(09)60780-7","article-title":"Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends","volume":"374","author":"Sun","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bvth.2025.100111_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.14740\/cr789","article-title":"Bioprosthetic valve thrombosis","volume":"9","author":"Sachdev","year":"2018","journal-title":"Cardiol Res"},{"issue":"4","key":"10.1016\/j.bvth.2025.100111_bib20","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jtcvs.2016.07.059","article-title":"Bioprosthetic valve thrombosis: are we not seeing the wood for the trees?","volume":"152","author":"Barlow","year":"2016","journal-title":"J Thoracic Cardiovasc Surg"},{"issue":"7","key":"10.1016\/j.bvth.2025.100111_bib21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/CIRCULATIONAHA.116.026793","article-title":"Direct oral anticoagulants in patients with atrial fibrillation and valvular heart disease other than significant mitral stenosis and mechanical valves: a meta-analysis","volume":"135","author":"Siontis","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bvth.2025.100111_bib22","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.ajkd.2021.02.328","article-title":"Oral anticoagulant agents in patients with atrial fibrillation and CKD: a systematic review and pairwise network meta-analysis","volume":"78","author":"Su","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.bvth.2025.100111_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40261-021-01016-7","article-title":"Efficacy and safety of direct oral anticoagulants vs warfarin in patients with chronic kidney disease and dialysis patients: a systematic review and meta-analysis","volume":"41","author":"Chen","year":"2021","journal-title":"Clin Drug Investig"},{"issue":"8","key":"10.1016\/j.bvth.2025.100111_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034176","article-title":"Anticoagulation for patients with concomitant atrial fibrillation and end-stage renal disease: a systematic review and network meta-analysis","volume":"13","author":"Kao","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.bvth.2025.100111_bib25","first-page":"CD011373","article-title":"Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease","volume":"11","author":"Kimachi","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bvth.2025.100111_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/17539447221093963","article-title":"Direct oral anticoagulation in atrial fibrillation and heart valve surgery-a meta-analysis and systematic review","volume":"16","author":"Gerfer","year":"2022","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.bvth.2025.100111_bib27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10557-023-07451-2","article-title":"Direct oral anticoagulants in patients with atrial fibrillation and significant mitral stenosis\u2014a preliminary meta-analysis","volume":"38","author":"Zhang","year":"2024","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327225000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327225000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:11:42Z","timestamp":1772032302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327225000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2950327225000683"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2025.100111","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DOACs vs warfarin in AF with comorbid CKD or valvular disease: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2025.100111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100111"}}